Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by growth of kidney cysts and glomerular filtration rate (GFR) decline. Metformin was found to impact cystogenesis in preclinical models of polycystic disease, is generally considered safe and may be a promising candidate for clin...

Full description

Bibliographic Details

Published in:	Kidney international Vol. 100; no. 3; p. 684
Main Authors:	Perrone, Ronald D, Abebe, Kaleab Z, Watnick, Terry J, Althouse, Andrew D, Hallows, Kenneth R, Lalama, Christina M, Miskulin, Dana C, Seliger, Stephen L, Tao, Cheng, Harris, Peter C, Bae, Kyongtae Ty
Format:	Journal Article
Language:	English
Published:	United States 01.09.2021
Subjects:	Adult Cysts Disease Progression Glomerular Filtration Rate Humans Kidney Metformin - adverse effects Polycystic Kidney, Autosomal Dominant - drug therapy clinical trial total kidney volume metformin autosomal dominant polycystic kidney disease estimated glomerular filtration rate
ISSN:	1523-1755, 1523-1755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!